We previously reported that lung edema clearance was stimulated by dopamine (DA). The purpose of this study was to determine whether the DA-mediated stimulation of edema clearance occurs via an adrenergic or dopaminergic regulation of alveolar epithelial Na,K-ATPase. When isolated perfused rat lungs were coinstilled with DA and SCH 23390 (a specific D 1 receptor antagonist), there was a dose-dependent attenuation of the stimulatory effects of DA. Coinstillation with S-sulpiride (a specific D 2 receptor antagonist) or propranolol (a ␤ -adrenergic antagonist) did not alter DA-stimulated clearance. Similarly, the specific dopaminergic D 1 agonist fenoldopam increased lung edema clearance, but quinpirole (a specific dopaminergic D 2 agonist) did not. The concept that clearance of lung edema could be accelerated by enhancing the sodium-transporting ability of the pulmonary alveolar epithelium, formulated only in the last decade (1-5), has potential clinical significance. Upregulation of sodium transport systems associated with enhancement of lung edema clearance has been demonstrated for pathological conditions in which lung fluid balance promotes edema formation, such as oxygen toxicity, sepsis, or hemorrhagic shock, as well as in normal lungs stimulated by catecholamines and other mechanisms (1, 6-13).
The concept that clearance of lung edema could be accelerated by enhancing the sodium-transporting ability of the pulmonary alveolar epithelium, formulated only in the last decade (1) (2) (3) (4) (5) , has potential clinical significance. Upregulation of sodium transport systems associated with enhancement of lung edema clearance has been demonstrated for pathological conditions in which lung fluid balance promotes edema formation, such as oxygen toxicity, sepsis, or hemorrhagic shock, as well as in normal lungs stimulated by catecholamines and other mechanisms (1, (6) (7) (8) (9) (10) (11) (12) (13) .
It has been reported that lung edema clearance can be increased by ␤ -adrenergic stimulation (1, (10) (11) (12) (13) . We have recently reported that dopamine (DA) also increases lung edema clearance in rat lungs, and that this clearance is dependent upon sodium transport (14) . In the present study, we demonstrate that DA mediates an increase in active sodium transport not through the previously described ␤ -adrenergic pathway, but via a novel mechanism where activation of dopaminergic D 1 type receptors results in increased lung edema clearance.
METHODS

Isolated Perfused Lungs
The isolated perfused lung preparation used in our laboratory has been described in detail (7, 8, 14, 15) . Briefly, lungs were isolated from anesthetized rats (65 mg/kg pentobarbital sodium [Nembutal] intraperitoneally) after a 10-min ventilation with 100% O 2 . The pulmonary artery and left atrial appendage were cannulated and perfused with a solution of 3% bovine serum albumin (BSA) in buffered physiological salt solution. Fluorescein (FITC)-labeled albumin was added to the perfusate to monitor leakage of protein from the vascular space into the airways. The recirculating volume of the constant pressure perfusion system was 90 ml; arterial and venous pressures were set at 12 and 0 cm H 2 O, respectively. The lungs were excised from the thoracic cavity and placed in a "pleural" bath (100 ml) filled with the same BSA solution. The entire system was maintained at 37 Њ C in a water bath. The lungs were then instilled via the tracheal catheter with 5 ml BSA containing Evans blue dye (EBD)-labeled albumin, 22 Na ϩ , and 3 H-mannitol. Samples were taken from the instillate, perfusate, and bath solutions after a 10-min equilibration period and 60 min later. Absorbance at 620 nm (for EBD-labeled albumin), fluorescence (excitation 487 nm, emission 520 nm; for FITC-labeled albumin), and scintillation counting (for 22 Na ϩ and 3 H-mannitol) were measured in centrifuged samples from each compartment.
Calculations
The derivation of all equations involved in the mathematical model of edema clearance has been previously described in detail (14, 15) . Concentration of EBD-labeled albumin was used to estimate airspace volume. As virtually all EBD-labeled albumin remains in the airspace, instillate volume (V) at a given time can be calculated from the increase in airspace protein concentration. The total unidirectional outflux of Na ϩ from the alveolar space, a result of active transport and passive movement, was calculated from the rate of loss of 22 Na ϩ from the airspaces. Passive sodium flux was calculated by subtracting the active sodium flux, calculated from the rate of net fluid clearance, from the total. Similarly, the unidirectional volume flux of mannitol was calculated from the rate of loss of 3 H-mannitol from the airspaces. Albumin flux from the pulmonary circulation into the alveolar space was determined from the fraction of FITC-labeled albumin that appeared in the alveolar instillate during the experimental protocol. For comparison, fluxes are reported as volume fluxes (volume/time) by using the appropriate solute concentrations.
Alveolar Type II (ATII) Cell Isolation and Culture
Lungs from anesthetized rats were perfused free of blood and excised from the thoracic cavity. ATII cells were isolated as previously described (16) . Lungs were filled and incubated with an elastase solution (15 U/ml) for 20 min at 37 Њ C. The tissue was minced and sequentially filtered through sterile 150 m and 15 m nylon mesh, then purified by differential adherence to IgG-coated plastic dishes. Viability of ATII cell preparations was Ͼ 95% as assessed by exclusion of trypan blue. The yield was approximately 3 ϫ 10 7 cells/animal with a purity of 85 to 90% as determined by staining for lamellar bodies with Papanicolaou or phosphine 3R and tannic acid (16) . Isolated cells were suspended in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum with 2 mM L -glutamine, 40 mg/ml gentamicin, 100 U/ml penicillin, and 100 mg/ml streptomycin and plated at a density of 4 ϫ 10 5 /cm 2 in plastic tissue-culture wells. Nonadherent cells were removed after 24 h incubation in a humidified atmosphere of 5% CO 2 /95% air at 37 Њ C. Adherent cells were used by the third day of culture for all further studies.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
The reverse transcriptase (RT) reaction was performed using the Superscript preamplification system by GIBCO-BRL (Gaithersburg, MD) following the manufacturer's instruction. One g of total RNA is converted into complementary DNA (cDNA), after denaturing at 70 Њ C for 15 min, by incubation with a buffer containing oligo-dT primers, the RT enzyme, and deoxynucleoside triphosphates (dNTPs) mix for 50 min at 42 Њ C. The RT enzyme is then inactivated by incubation at 70 Њ C for 15 min and the RNA removed by incubation with ribonuclease H (RNase H) for 20 min at 37 Њ C. The resultant cDNAs are amplified by polymerase chain reaction (PCR) using D1-specific primers, then analyzed by 2% agarose gel electrophoresis (17) .
Western Blot Analysis
Dopaminergic receptor characterization was determined by Western blot analysis. Proteins were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 6 to 10% polyacrylamide gradient gel and transferred to nitrocellulose membranes (Hybond C; Amersham, Arlington Heights, IL). After transfer was completed (3 h at 1 A), the membranes were quenched at room temperature for 1 h with 7.5% casein in phosphate-buffered saline (PBS) containing 0.1% Tween 20. Incubation with specific dopaminergic antibodies was performed overnight at 4 Њ C. The D1 receptor antibodies were purchased from Santa Cruz Biochemicals (Santa Cruz, CA). The membranes were rinsed five times with PBS, 1% Tween 20 followed by incubation with a horseradish peroxide-conjugated goat antimouse secondary antibody (Bio-Rad, Richmond, CA) for 1 h. Blots were developed as previously described with an enhanced chemiluminescence (ECL) detection kit (Amersham) used as recommended by the manufacturer.
Binding Assays
To determine saturability of binding, a modified method of Felder and colleagues was used (18) . All studies were performed on ATII cells grown in 12-well tissue culture plates for 2 d. Cells were incubated with 125 I-SCH 23982 (0.1 nM to 100 nM) (NEN Life Science Products, Boston, MA) in the presence and absence of a 1,000-fold excess of unlabeled ligand (SCH 23390, 0.1 to 100 m) to determine nonspecific binding. Cells were rinsed three times with excess incubation buffer at 4 Њ C, solubilized, and placed in scintillation vials with scintillation cocktail for radioactive counting. Specific binding was defined as the difference between radiolabeled ligand bound in the absence and in the presence of unlabeled ligand. The incubation time of 60 min was chosen for equilibrium based on preliminary binding kinetics studies.
Experimental Protocols
A total of 78 experiments were conducted in the isolated perfused rat lung model. Drugs were added to the alveolar instillate and the compounds were present at the final concentration from the initial instillation.
Miscellaneous
DA (Sigma Chemical Co., St. Louis, MO) was freshly prepared before each experiment as a 1,000 ϫ stock in normal saline. SCH 23390 (RBI, Natick, MA) and fenoldopam (a gift from Neurex Pharmaceutical, Menlo Park, CA) were prepared as 10 mM stocks in water, quinpirole (RBI) was prepared as a 10 mM stock in 0.1 N HCl, and S-sulpiride (RBI) was prepared as a 10 mM stock in ethanol.
Statistical Analysis
All data are presented as mean Ϯ SEM. Analysis of variance (ANOVA) was used to test for differences between groups, followed by a multiple comparison test (Tukey) when the F statistic indicated significance.
RESULTS
Instilled DA (Figure 1, 10 Ϫ 4 M; Figure 2 , 10 Ϫ 6 M) increased edema clearance out of the alveoli of isolated perfused lungs. Because DA at high concentrations could potentially activate ␤ -adrenergic receptors, we carried out studies using the ␤ -adrenergic antagonist propranolol. Instillation of 10 Ϫ 4 M propranolol alone had no effect on basal lung edema clearance, and coinstillation of propranolol with 10 Ϫ 4 M DA produced an increase in clearance comparable to the increase seen with DA alone (Figure 1) . 
Dopamine or propranolol did not affect passive sodium or mannitol flux, or increase epithelial permeability to albumin (data not shown). Perfusate flow did not change in any of the experimental protocols (data not shown).
To investigate the role of dopaminergic receptor activation, we carried out studies using either specific D 1 or D 2 receptor antagonists coinstilled with DA, or specific D 1 or D 2 receptor agonists. Coinstillation of a dopaminergic D 1 receptor antagonist, SCH 23390 (19) (10 Ϫ 6 or 10 Ϫ 8 M), with 10 Ϫ 6 M DA inhibited the increased clearance observed with DA alone, whereas SCH 23390 (10 Ϫ 6 M) instilled alone had no effect on baseline clearance (Figure 2 ). Loss of the inhibitory effect of SCH 23390 was observed at 10 Ϫ 10 M. In contrast, coinstillation of a dopaminergic D 2 receptor antagonist, S-sulpiride (10 Ϫ 6 M), with 10 Ϫ 6 M DA did not inhibit the increased clearance observed with DA alone, and S-sulpiride instilled alone had no effect on baseline clearance (Figure 3) . None of the instilled agonists or antagonists had an effect on passive mannitol or sodium flux, epithelial permeability for albumin, or flows (Table 1) .
When the specific dopaminergic D 1 agonist fenoldopam (10 Ϫ 6 M) was instilled there was a significant increase in lung edema clearance, comparable to that seen with DA. In contrast, and in agreement with the antagonist studies, when the dopaminergic D 2 agonist quinpirole (10 Ϫ 6 M) (20) was instilled into the lungs, there was no increase in clearance (Figure 4) . Again, there was no effect on passive mannitol or sodium flux, epithelial permeability for albumin, or flows (data not shown).
RT-PCR demonstrated the presence of messenger RNA for the D 1 receptor in ATII cells. An amplification product of the predicted size (247 bp) for the D 1 receptor was detected in the RT-PCR reactions using extracted ATII cell RNA ( Figure  5) . Expression of the D 1 receptor protein in ATII cell basolateral membranes and whole cell homogenates was analyzed by Western blot. As shown in Figure 6 , rat lung ATII cell basolateral membranes reacted with antibodies specific for D 1 often treated with DA to increase natriuresis and diuresis (22) . These effects reflect, in part, inhibition of renal tubular Na,K-ATPase that leads to decreased sodium reabsorption (23, 24) . We have previously reported that the effect of DA in the alveolar epithelium is opposite to that in renal tubular epithelium, or most other previously studied epithelia, as DA increased active sodium transport and improved the ability of the lung to clear edema (14) .
DA can activate both ␤-adrenergic and dopaminergic receptors in a concentration-dependent manner (22) . Thus, we carried out three sets of studies in the isolated perfused lung to define the population of receptors involved in DA-stimulated lung edema clearance: the first using DA with propranolol to determine whether ␤-adrenergic receptors had a role in DA-stimulated lung edema clearance (Figure 1 ), a second using DA and a specific D 1 or D 2 antagonist (SCH 23390 or S-sulpiride, respectively, Figures 2 and 3) , and a third using a specific D 1 or D 2 agonist (fenoldopam or quinpirole, respectively, Figure 4) . Although previous studies have demonstrated that ␤-adrenergic agonists upregulate Na,K-ATPase and increase lung edema clearance in several models (1, 2, (10) (11) (12) (13) 25) , our data indicate that DA is not acting via activation of ␤-adrenergic receptors, suggesting a novel mechanism of sodium transport and edema clearance regulation.
The dopaminergic receptor antagonist and agonist studies strongly suggest that D 1 receptor activation mediates the effects observed with dopaminergic stimulation of lung edema clearance. When coinstilled with DA, SCH 23390 (a D 1 antagonist) inhibited DA-stimulated clearance to levels not different from control rat lungs, and fenoldopam (a D 1 agonist) significantly increased clearance to an extent similar to that seen with DA. The D 1 antagonist, SCH 23390, had no effect on the baseline reabsorption of fluid. In contrast, the results do not support a role for D 2 receptor short-term regulation of sodium transport in the pulmonary alveolar epithelium, as S-sulpiride (a D 2 antagonist) did not inhibit the DA-stimulated clearance, and quinpirole (a D 2 agonist) did not stimulate it.
RT-PCR demonstrated the presence of D 1 receptor messenger RNA (mRNA) in ATII cells ( Figure 5 ). Western blot analysis confirmed that the D 1 receptor protein is present in ATII cell basolateral membranes ( Figure 6 ). D 1 receptors were quantitated by the specific binding of 125 I-SCH 23982, a D 1 antagonist, in ATII cells (Figure 7 ). Taken together, these results suggest that in ATII cells DA mediates its short-term effects via the D 1 receptor.
Our observations demonstrate for the first time that the dopaminergic D 1 receptor is mainly expressed in the basolateral membrane of ATII cells. The data also suggest that activation of this receptor contributes to edema removal from the alveolar space. Our data further indicate that sodium transport in the lungs may be upregulated by administration of pharmacological agents that stimulate the D 1 receptor. Dopaminergic stimulation represents a novel and rapid mechanism to stimulate edema removal from the lungs and should be evaluated as a strategy in the treatment of patients with hypoxemic respiratory failure caused by pulmonary edema.
